PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGenome-editing study raises hopes for 'curing' cervical cancer

BioNews

Genome-editing study raises hopes for 'curing' cervical cancer

Published 10 October 2019 posted in News and appears in BioNews 1019

Author

Bernie Owusu-Yaw

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Australian researchers have successfully halted and eliminated cancer growth in tumour-bearing mice by injecting them with nanoparticles containing genome-editing machinery targeting cancer genes...

Australian researchers have successfully halted and eliminated cancer growth in tumour-bearing mice by injecting them with nanoparticles containing genome editing machinery targeting cancer genes.

'This is the first cure for any cancer using this technology,' said Professor Nigel McMillan, programme director at the Menzies Health Institute Queensland, Griffith University, who led the study.

'The nanoparticles search out the cancer-causing gene in cancer cells and "edit it" by introducing some extra DNA that causes the gene to be misread and stop being made,' he added.

In the study published in Molecular Therapy, the researchers used CRISPR/Cas9 genome editing technology to prevent the expression of a human papillomavirus (HPV) gene, called E7, that drives cervical cancer.

The CRISPR/Cas9 machinery was packaged into stealth nanoparticles and injected into mice with tumours that developed following transplantation with HPV cervical cancer cells. Mice that were transplanted with HPV-16 cervical cancer cells received three injections at 8, 12 and 16 days. The researchers observed that tumour growth was halted in these mice after 77 days and they out-lived untreated mice.

They also treated mice that were transplanted with HPV-18 cervical cancer cells with nanoparticles targeting the E7 gene. These mice were separated into two groups; one group received three injections whereas the other group received seven. Their findings show that tumour growth was temporarily halted but resumed again in the mice that received three injections. However, the tumours were completely cleared in mice that were injected at seven different time points.

These findings suggest that CRISPR/Cas9 therapy may be an effective treatment for cervical cancer, however further studies need to be carried out to determine the specificity and safety of this treatment before it can be trialled in humans.

'We know a third of all cancers in the world are caused by infectious organisms, so this treatment would be fantastic because we are targeting foreign genes, genes that are not normally in our genome,' Professor McMillan told ABC News.

'There are still many steps to go through before we get to the clinic stage,' he added.

Sources and References

  • 08/10/2019
    ABC News
    Cervical cancer 'cure' closer with gene-editing breakthrough, scientists say
  • 09/10/2019
    Griffith University
    Gene-editing breakthrough in battle against cancer
  • 29/08/2019
    Molecular Therapy
    Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors
  • 09/10/2019
    Daily Mail
    Scientists discover 'cure' for cervical cancer after breakthrough using gene-editing technology

Related Articles

PET BioNews
News
22 January 2021 • 2 minutes read

Organoids give insight into the development of cervical cancer

by Dr Rachel Montgomery

Molecular changes that give rise to cervical cancer have been identified using novel 'organoid' models...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
7 February 2020 • 3 minutes read

CRISPR-edited cells for cancer treatment appear safe

by Christina Burke

Results published from a pioneering clinical trial in the USA have confirmed for the first time that treatment with genome-edited cells appears safe...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
8 November 2019 • 2 minutes read

Genome editing seems safe suggests first study in US patients

by Shaoni Bhattacharya

Early results from the first clinical trial to use CRISPR/Cas9 genome editing in three cancer patients in the USA suggest the approach is safe...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 April 2019 • 2 minutes read

Cancer gene targets found and ranked using CRISPR

by Charlotte Spicer

UK scientists have used genome-editing to identify hundreds of potential drug targets for new cancer treatments...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 July 2018 • 2 minutes read

Genome editing turns cancer cells against their own

by Jen Willows

Cancer cells may be edited to attack tumours according to new research published in Science Translational Medicine...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 May 2018 • 2 minutes read

Genome editing could slow the growth of pancreatic cancer

by Shaoni Bhattacharya

Researchers have slowed the growth of pancreatic cancer by harnessing genome editing to remove key molecules implicated in its spread...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 June 2017 • 2 minutes read

Genome editing used to slow cancer growth

by Annabel Slater

US scientists have delayed cancer cell growth by using genome editing to remove a protein...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« National Academy of Sciences pulls misleading genome editing video

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856